MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acvd.2017.04.010

Медицинская библиотека · Archives of cardiovascular diseases · 2017

Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.

Maillard Luc, Tavildari Alain, Barra Nicolas, Billé Jacques, Joly Patrick, Peycher Patrick, Silvestri Marc, Vochelet François

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The COBRA PzF coronary stent, which has a unique nano-coating of Polyzene-F, was developed to reduce the risk of stent thrombosis.

AIMS: To report procedural and 1-year clinical outcomes following COBRA PzF coronary stent implantation in a real-world percutaneous coronary intervention (PCI) registry.

METHODS

All patients assigned to treatment with the COBRA PzF in the GCS Axium Rambot Center, Aix-en-Provence, France between February 2013 to June 2014 were prospectively enrolled.

RESULTS

Among 100 patients (71% men, mean±standard error age 71.4±11.0 years), 38% had acute coronary syndromes. The population was consistent with real-world experience and included patients with multiple co-morbidities and 26% with diffuse multivessel disease. A total of 151 lesions were treated with 166 stents, including 26% of lesions with a type B2 or C classification. Pre- and post-procedural quantitative coronary angiography analyses showed a mean acute gain of 2.2±0.2mm. Angiographic success was achieved in all cases. One-year follow-up was available for all patients and the target vessel failure (composite of all-cause mortality, myocardial infarction or target vessel revascularization) rate was 12%, including 2% mortality (end-stage cardiomyopathy), 5% myocardial infarction (five periprocedural myocardial infarctions with isolated troponin elevation without chest pain or Q waves) and 5% target lesion revascularization. There were no cases of definite stent thrombosis.

CONCLUSION

The COBRA PzF stent was safe and effective in routine practice. One-year follow-up was associated with excellent clinical outcomes and compared favourably with current devices. These results are very promising in a real-world population of complex patients, and further study is warranted.

Для цитирования: Maillard Luc, Tavildari Alain, Barra Nicolas, Billé Jacques, Joly Patrick, Peycher Patrick, Silvestri Marc, Vochelet François. Immediate and 1-year follow-up with the novel nanosurface modified COBRA PzF stent.. Archives of cardiovascular diseases. 2017. DOI: 10.1016/j.acvd.2017.04.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.